Brevianamide F

Basic Information

View in Editor

CAS Number

38136-70-8

Molecular Formula

C16H17N3O2

Molecular Weight

283.33 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Physical State

Powder

Melting Point

176-179 ºC

Boiling Point

633.2°C at 760 mmHg

SMILES

View in Editor

C1CC2C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43

InChI

InChI=1S/C16H17N3O2/c20-15-14-6-3-7-19(14)16(21)13(18-15)8-10-9-17-12-5-2-1-4-11(10)12/h1-2,4-5,9,13-14,17H,3,6-8H2,(H,18,20)/t13-,14-/m0/s1

InChIKey

RYFZBPVMVYTEKZ-KBPBESRZSA-N

LogP

1.1997999999999995

Topological Polar Surface Area

65.2 Å²

Hydrogen Bond Donor/Acceptor

2 / 5

Complexity

453

Safety Information

View Safety Information

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Synonyms & References

English

(3S,8aS)-3-(1H-indol-3-ylmethyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
(3S,8aS)-3-(1H-indol-3-ylmethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
Brevianamide F
Cyclo(L-Pro-L-Trp)
Cyclo(L-Pro-L-Trp-)
Cyclo-L-tryptophyl-L-proline
L-Prolyl-L-tryptophan anhydride
Prolyltryptophanyldiketopiperazine
cyclo-L-Prolyl-L-tryptophanyl
(3S,8aS)-Hexahydro-3-(1H-indol-3-ylmethyl)pyrrolo[1,2-a]pyrazine-1,4-dione
Cyclo-L-Trp-L-Pro
cyclo-(Trp-Pro)
cyclo-L-tryptophanyl-L-proline
tryptophan-proline diketopiperazine
L-tryptophyl-L-proline cyclic anhydride
AK169895
Cyclo(L-Trp-L-Pro)
cyclo-(L-Trp-L-Pro)
cyclo-L-proline-L-pryptophan
cyclo-L-pryptophan-L
cyclo-L-pryptophan-L-proline
(3S,8aS)-3-[(1H-indol-3-yl)methyl]-octahydropyrrolo[1,2-a]piperazine-1,4-dione
(3S,8aS)-Hexahydro-3-(1H-indol-3-ylmethyl)pyrrolo[1,2-a]pyrazine-1,4-dione; Cyclo(L-Pro-L-Trp); Cyclo-L-tryptophyl-L-proline; L-Prolyl-L-tryptophan Anhydride Prolyltryptophanyldiketopiperazine; Cyclo-L-Prolyl-L-tryptophanyl
SCHEMBL2018181
38136-70-8
QRP
s6751
(3S,8aS)-3-((1H-Indol-3-yl)methyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
MFCD29917326
DTXSID10959075
A873918

MDL Number

MFCD29917326

FAQ

What regulatory guidelines apply to Brevianamide F (CAS: 38136-70-8)?

Brevianamide F (CAS: 38136-70-8) is subject to various regulations including GHS classification, which categorizes it based on its health, environmental, and physical hazards. It is also regulated under the REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) regulations in the EU, which requires manufacturers and importers to register chemicals and manage their risks. In the US, the FDA and EPA have specific requirements for the handling, storage, and disposal of this compound to ensure public and environmental safety.

Are there alternatives to Brevianamide F in synthesis?

There are several alternatives to Brevianamide F in synthesis. For instance, similar compounds such as brevianamides A, B, and C can be used as substitutes. Additionally, researchers often explore the use of synthetic analogs and isomers, which can offer similar biological activities while potentially being easier to synthesize or more stable. Common alternative reagents include various amino acids and amides, which can serve as precursors or building blocks in the synthesis of Brevianamide F.

What is the market or research trend for Brevianamide F?

Brevianamide F (CAS: 38136-70-8) is currently experiencing a growing research interest, particularly in its potential as a natural product with bioactive properties. The market trend reflects increasing demand for natural compounds with pharmaceutical and biotechnological applications. Recent studies have focused on understanding its structural characteristics, biological activities, and potential uses in drug discovery and development. The research trend is also influenced by the compound's unique chemical structure and its reported effects on various biological pathways.

How should waste containing Brevianamide F be handled?

Waste containing Brevianamide F (CAS: 38136-70-8) should be handled with caution to ensure environmental and occupational safety. It is recommended to collect waste in appropriate containers and label them clearly. For disposal, incineration is a common method, requiring specialized facilities and following strict safety protocols. Alternatively, professional waste disposal services can be utilized to handle the waste safely. It is essential to follow local, state, and federal regulations regarding the disposal of hazardous chemicals to prevent environmental contamination and protect public health.